Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma
Abstract Tumor-secreted factors contribute to the development of a microenvironment that facilitates the escape of cancer cells from immunotherapy. In this study, we conduct a retrospective comparison of the proteins secreted by hepatocellular carcinoma (HCC) cells in responders and non-responders a...
Main Authors: | Chunxiao Liu, Chenhao Zhou, Weiya Xia, Yifan Zhou, Yufan Qiu, Jialei Weng, Qiang Zhou, Wanyong Chen, Ying-Nai Wang, Heng-Huan Lee, Shao-Chun Wang, Ming Kuang, Dihua Yu, Ning Ren, Mien-Chie Hung |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-45215-0 |
Similar Items
-
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
by: Jessica Castro, et al.
Published: (2021-01-01) -
Red-Light-Activatable AND-Gated Antitumor Immunosuppressant
by: Ziqi Zhou, et al.
Published: (2023-09-01) -
GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism
by: Qiang Zhou, et al.
Published: (2022-10-01) -
Semisynthesis of Human Ribonuclease–S
by: Sayers, Jessica, et al.
Published: (2022) -
Semisynthesis of Human Ribonuclease–S
by: Sayers, Jessica, et al.
Published: (2022)